Evaluation of Clinical Outcomes After Introduction of a Dedicated Infectious Diseases-Critical Care Medicine Service in Critical Care Units
- PMID: 34322562
- PMCID: PMC8312519
- DOI: 10.1093/ofid/ofab182
Evaluation of Clinical Outcomes After Introduction of a Dedicated Infectious Diseases-Critical Care Medicine Service in Critical Care Units
Abstract
Background: Infection is a leading cause of admission to intensive care units (ICUs), with critically ill patients often receiving empiric broad-spectrum antibiotics. Nevertheless, a dedicated infectious diseases (ID) consultation and stewardship team is not routinely established. An ID-critical care medicine (ID-CCM) pilot program was designed at a 400-bed tertiary care hospital in which an ID attending was assigned to participate in daily rounds with the ICU team, as well as provide ID consultation on select patients. We sought to evaluate the impact of this dedicated ID program on antibiotic utilization and clinical outcomes in patients admitted to the ICU.
Methods: In this single-site retrospective study, we analyzed antibiotic utilization and clinical outcomes in patients admitted to an ICU during the postintervention period from January 1 to December 31, 2017, and compared it to antibiotic utilization in the same ICUs during the preintervention period from January 1 to December 31, 2015.
Results: Our data showed a statistically significant reduction in usage of most frequently prescribed antibiotics including vancomycin, piperacillin-tazobactam, and cefepime during the intervention period. When compared to the preintervention period there was no difference in-hospital mortality, hospital length of stay, and readmission.
Conclusions: With this multidisciplinary intervention, we saw a decrease in the use of the most frequently prescribed broad-spectrum antibiotics without a negative impact on clinical outcomes. Our study shows that the implementation of an ID-CCM service is a feasible way to promote antibiotic stewardship in the ICU and can be used as a strategy to reduce unnecessary patient exposure to broad-spectrum agents.
Keywords: antibiotic stewardship; critical care; infectious diseases; intensive care unit.
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures
Similar articles
-
Impact of Infectious Diseases Team Consultation on Antimicrobial Use, Length of Stay and Mortality.Am J Med Sci. 2015 Sep;350(3):191-4. doi: 10.1097/MAJ.0000000000000546. Am J Med Sci. 2015. PMID: 26263235
-
Implementation and outcomes of hospital-wide computerized antimicrobial approval system and on-the-spot education in a traumatic intensive care unit in Taiwan.J Microbiol Immunol Infect. 2018 Oct;51(5):672-680. doi: 10.1016/j.jmii.2017.10.004. Epub 2017 Nov 11. J Microbiol Immunol Infect. 2018. PMID: 29167061
-
Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.Pharmacotherapy. 2016 May;36(5):463-71. doi: 10.1002/phar.1738. Epub 2016 Apr 1. Pharmacotherapy. 2016. PMID: 26952639
-
Half of Prescribed Antibiotics Are Not Needed: A Pharmacist-Led Antimicrobial Stewardship Intervention and Clinical Outcomes in a Referral Hospital in Ethiopia.Front Public Health. 2020 Apr 9;8:109. doi: 10.3389/fpubh.2020.00109. eCollection 2020. Front Public Health. 2020. PMID: 32328474 Free PMC article.
-
Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.J Intensive Care Med. 2018 Dec;33(12):647-655. doi: 10.1177/0885066618762747. Epub 2018 Mar 13. J Intensive Care Med. 2018. PMID: 29534630 Review.
References
-
- Dowling HF, Lepper MH, Jackson GG. Clinical significance of antibiotic-resistant bacteria. J Am Med Assoc 1955; 157:327–31. - PubMed
-
- Finland M. Emergence of antibiotic-resistant bacteria. N Engl J Med 1955; 253:1019–28; concl. - PubMed
-
- ABUSE of antibiotics. Lancet 1955; 268:1059–60. - PubMed
-
- The White House. National strategy for combating antibiotic-resistant bacteria. Available at: https://obamawhitehouse.archives.gov/sites/default/files/docs/carb_natio.... Accessed 1 September 2018.
-
- The White House. Antibiotic use in the United States, 2017: progress and opportunities. Available at: https://www.cdc.gov/antibiotic-use/stewardship-report/hospital.html. Accessed 1 September 2018.